| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.31 | 9e-16 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-15 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-13 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-13 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.28 | 7e-13 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-11 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.26 | 9e-11 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-10 |